Northern Trust Corp Vbi Vaccines Inc Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.29 - $0.64 $1,291 - $2,849	-4,452 Reduced 0.28%	1,589,672 $476,000
Q4 2022 Feb 13, 2023	SELL	$0.38 - $22.5 $81,248 - $4.81 Million	-213,813 Reduced 11.83%	1,594,124 $621,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $39,149 - $1.25 Million	-53,629 Reduced 2.88%	1,807,937 $1.28 Million
Q2 2022 Aug 12, 2022	SELL	$0.66 - $1.81 $19,112 - $52,413	-28,958 Reduced 1.53%	1,861,566 $1.51 Million
Q1 2022 May 13, 2022	SELL	$1.27 - $2.47 $124,240 - $241,632	-97,827 Reduced 4.92%	1,890,524 $3.14 Million
Q4 2021 Feb 08, 2022	BUY	$2.21 - $3.22 $150,761 - $219,661	68,218 Added 3.55%	1,988,351 $4.65 Million
Q3 2021 Nov 15, 2021	SELL	$2.8 - $3.72 $284,169 - $377,539	-101,489 Reduced 5.02%	1,920,133 $5.97 Million
Q2 2021 Aug 13, 2021	SELL	$2.61 - $4.17 $102,593 - $163,914	-39,308 Reduced 1.91%	2,021,622 $6.77 Million
Q1 2021 May 12, 2021	SELL	$2.91 - $4.32 $109,739 - $162,911	-37,711 Reduced 1.8%	2,060,930 $6.41 Million
Q4 2020 Feb 11, 2021	BUY	$2.15 - $3.5 $119,445 - $194,446	55,556 Added 2.72%	2,098,641 $5.77 Million
Q3 2020 Nov 16, 2020	BUY	$2.77 - $6.17 $105,866 - $235,811	38,219 Added 1.91%	2,043,085 $5.84 Million
Q2 2020 Aug 14, 2020	BUY	$0.87 - $3.13 $121,649 - $437,658	139,827 Added 7.5%	2,004,866 $6.21 Million
Q1 2020 May 14, 2020	BUY	$0.73 - $1.91 $126,619 - $331,291	173,451 Added 10.25%	1,865,039 $1.77 Million
Q4 2019 Feb 14, 2020	BUY	$0.48 - $1.38 $341,161 - $980,839	710,753 Added 72.46%	1,691,588 $2.33 Million
Q3 2019 Nov 13, 2019	BUY	$0.47 - $1.05 $358,171 - $800,169	762,066 Added 348.34%	980,835 $462,000
Q2 2019 Aug 13, 2019	BUY	$0.65 - $2.12 $42,560 - $138,811	65,477 Added 42.71%	218,769 $256,000
Q1 2019 May 13, 2019	BUY	$1.54 - $2.01 $147,504 - $192,521	95,782 Added 166.55%	153,292 $286,000
Q3 2018 Nov 14, 2018	BUY	$1.75 - $2.93 $22,881 - $38,309	13,075 Added 29.43%	57,510 $139,000
Q2 2018 Aug 14, 2018	SELL	$2.75 - $3.85 $690,010 - $966,015	-250,913 Reduced 84.96%	44,435 $122,000
Q1 2018 May 09, 2018	SELL	$3.5 - $4.47 $168 - $214	-48 Reduced 0.02%	295,348 $1.03 Million
Q4 2017 Feb 14, 2018	BUY	$3.29 - $5.03 $307,118 - $469,545	93,349 Added 46.2%	295,396 $1.26 Million
Q3 2017 Nov 13, 2017	BUY	$3.15 - $4.01 $636,448 - $810,208	202,047	202,047 $778,000

Others Institutions Holding VBIV

# of Institutions

Shares Held

688K

Call Options Held

Put Options Held

Frontier Wealth Management LLC Kansas City, MO

602K
Shares

$12,036
0.01% of portfolio
ETF Managers Group, LLC Summit, NJ

85.7K
Shares

$1,714
0.0% of portfolio

View Full List

About VBI Vaccines Inc

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

More about VBIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account